Safety of fecal based bacteriotherapies are primarily based on the health of the stool donors. We employ vigorous donor screening metrics, adverse event tracking, and a 90-day quarantine period to ensure that all of our HMTs are as free of pathogenic organisms as possible.
Our donor screening criteria is based off of the excellent OpenBiome qualifications, with additional criteria added for pathogenic organisms, generalized inflammation due to unknown causes, and digestive health. First, a donor must pass a 50-point health questionnaire. Next, a donor must pass a comprehensive health check-up, comprised of a more than 60 infectious disease and pathogen target panel. This donor screening process is the most rigorous of any stool bank globally.
The Asia Microbiota Bank works with a major Hong Kong-based HOKLAS certified pathology laboratory for donor screening. Additionally, our metagenomic sequencing is handled by two global companies, which also provide metagenomic sequencing for the US FDA and major universities.
To receive more detailed information on our screening protocol, please email or call us at the contact information listed.
Similar to a blood donor, a stool donor must go through a rigorous health screening consisting of a blood test and a stool test, checking for more than 20 different infectious pathogens. Once a prospective donor is confirmed to be disease free AND super healthy, he or she is eligible to be a part of our donor registry.